SCHEMBL28959203

SCHEMBL28959203

COc1ccc(Oc2ccc(-c3nc(N)c4cc(OCCCN5CCOCC5)c(OC)cc4n3)cc2)cc1OC

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.57
▸ KDM4E B2RXH2 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ AXL P30530 1/20 0.53
▸ MAP2K1 Q02750 4/20 0.52
▸ RAF1 P04049 2/20 0.52
▸ MAPK3 P27361 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ SRC P12931 7/20 0.51
▸ HPGD P15428 1/20 0.51
▸ HIF1A Q16665 1/20 0.51
▸ TLR9 Q9NR96 1/20 0.50
▸ PDPK1 O15530 1/20 0.49
▸ LMNA P02545 1/20 0.48
▸ ATM Q13315 1/20 0.48
▸ KDR P35968 2/20 0.47
▸ ABL1 P00519 1/20 0.46
▸ BCR P11274 1/20 0.46
▸ SPIN1 Q9Y657 1/20 0.46
▸ EHMT2 Q96KQ7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30017764 1.00 ALDH1A1 (0.57) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL28959189 0.92 ALDH1A1 (0.54) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL28959164 0.92 MAPT (0.52) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL28959210 0.92 AXL (0.54) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL30017995 0.90 MAP2K1 (0.52) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL28959214 0.90 MAP2K1 (0.52) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL28959195 0.90 SRC (0.51) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL30017992 0.90 MAP2K1 (0.52) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL28965139 0.90 MAP2K1 (0.52) ALDH1A1KDM4EMAPTAXLMAP2K1
SCHEMBL30017460 0.90 MAP2K1 (0.51) ALDH1A1KDM4EMAPTAXLMAP2K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403557-A Quinoline and quinazoline compounds as fourth-generation EGFR (epidermal growth factor receptor) inhibitor and application thereof 华东理工大学 2022-11-29 — — CN disclosed
Send feedback